Neuren Pharmaceuticals (ASX:NEU) Receives Priority Review Voucher Sale Proceeds
Neuren Pharmaceuticals (ASX:NEU) receives one-third of proceeds from Priority Review Voucher sale, boosting its financial position.
The Hub of Australian Finance News
Neuren Pharmaceuticals (ASX:NEU) receives one-third of proceeds from Priority Review Voucher sale, boosting its financial position.
Iron Road Ltd (ASX:IRD) announces an on-market share buy-back program up to 5% of issued capital to enhance its capital management strategy.
Nyrada Inc (ASX:NYR) has commenced its Phase Ia clinical trial for NYR-BI03, following HREC approval.
Sigma Healthcare (ASX:SIG) upgrades its FY25 EBIT guidance to $64-$70 million, driven by improved operational performance and strong contract execution.
RLF AgTech Ltd (ASX:RLF) successfully raises $2.4M through its Entitlement Issue, demonstrating strong investor support and funding its growth strategy.
European Lithium (ASX:EUR) announces Critical Metals Corp’s US$22.5 million private placement to advance Greenland REE and Wolfsberg Lithium Projects.
DigitalX Limited (ASX:DCC) updates January 2025 treasury holdings and fund performance, highlighting increased Solana holdings and strong returns.
Aureka Limited (ASX:AKA) launches dual diamond drilling programs at Tandarra Joint Venture and Irvine Projects, advancing its 7,000m 2025 exploration plan.
Cyprium Metals (ASX:CYM) closes its Entitlement Offer, raising A$1.53M with a 51% shareholder take-up rate.
Pact Group Holdings Ltd (ASX:PGH) responds to ASX price query, outlining financial performance and upcoming half-year earnings release.